Alpha 2.0
Login Register
» Articles » PMID: 35022757

Loss of Humoral Response 3 Months After SARS-CoV-2 Vaccination in the CKD Spectrum: the Multicentric SENCOVAC Study

Overview
Journal Nephrol Dial Transplant
Publisher Oxford University Press
Specialties General Surgery
Nephrology
Date 2022 Jan 13
PMID 35022757
Authors
Borja Quiroga
Maria Jose Soler
Alberto Ortiz
Amparo Bernat
Ana Beatriz Munoz Diaz
Carlos Jesus Jarava Mantecon
Virginia Olinda Gomez Perez
Carmen Calderon Gonzalez
Michal cervienka
Auxiliadora Mazuecos
Juan Manuel Cazorla
Manuel Carnerero Di Riso
Shaira Martinez
Mayra Ortega Diaz
Rafael Lucena Valverde
Maria Gabriela Sanchez Marquez
Carolina Lancho Novillo
Emilio Gonzalez Parra
Carolina Gracia-Iguacel
Maria Teresa Rodrigo de Tomas
Maria Cinta Aguilar Cervera
Martin Giorgi
Patricia Munoz Ramos
Nicolas Macias Carmona
Nestor Toapanta
Secundino Cigarran
Juan Carlos Ruiz San Millan
Raquel Santana Estupinan
Marta Crespo
Blanca Villacorta Linaza
Maria Isabel Jimeno Martin
Laura Rodriguez-Osorio Jimenez
Sagrario Soriano
Dione Gonzalez Ferri
Maria Soledad Pizarro Sanchez
Alejandra Yugueros
Alba Leyva
Jose Rojas
Ron T Gansevoort
Patricia de Sequera
Affiliations
Soon will be listed here.
Citing Articles

Determinants of protective humoral response to mRNA-1273 and BNT162b2 vaccines in peritoneal dialysis patients: a prospective cohort study.

Dimitrov Y, Krummel T, Chantrel F, Heibel F, Kribs M, Hannedouche T BMC Nephrol. 2024; 25(1):391.

PMID: 39482652 PMC: 11529480. DOI: 10.1186/s12882-024-03789-3.

Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination.

De Bouver C, Bouziotis J, Wijtvliet V, Arien K, Marien J, Heyndrickx L Virol J. 2024; 21(1):138.

PMID: 38872127 PMC: 11170792. DOI: 10.1186/s12985-024-02410-1.

What has vaccination against COVID-19 in CKD patients taught us?.

Rossi M, Pessolano G, Gambaro G J Nephrol. 2023; 36(5):1257-1266.

PMID: 37140817 PMC: 10157569. DOI: 10.1007/s40620-023-01640-w.

.

Quiroga B, Soler M, Ortiz A, de Sequera P Nefrologia. 2022; .

PMID: 36540904 PMC: 9756643. DOI: 10.1016/j.nefro.2022.12.006.

Long-Term Dynamic Humoral Response to SARS-CoV-2 mRNA Vaccines in Patients on Peritoneal Dialysis.

Quiroga B, Soler M, Ortiz A, Gansevoort R, Leyva A, Rojas J Vaccines (Basel). 2022; 10(10).

PMID: 36298603 PMC: 9609237. DOI: 10.3390/vaccines10101738.

References
1.
Puranik A, Lenehan P, Silvert E, Niesen M, Corchado-Garcia J, OHoro J . Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection. Med. 2021; 3(1):28-41.e8. PMC: 8664708. DOI: 10.1016/j.medj.2021.12.002. View
2.
Muller L, Andree M, Moskorz W, Drexler I, Walotka L, Grothmann R . Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination. Clin Infect Dis. 2021; 73(11):2065-2072. PMC: 8135422. DOI: 10.1093/cid/ciab381. View
3.
Levin E, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S . Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months. N Engl J Med. 2021; 385(24):e84. PMC: 8522797. DOI: 10.1056/NEJMoa2114583. View
4.
Davidovic T, Schimpf J, Abbassi-Nik A, Stockinger R, Sprenger-Mahr H, Lhotta K . Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost. Kidney Int. 2021; 100(6):1334-1335. PMC: 8516134. DOI: 10.1016/j.kint.2021.10.006. View
5.
Embi P, Levy M, Naleway A, Patel P, Gaglani M, Natarajan K . Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(44):1553-1559. PMC: 8568092. DOI: 10.15585/mmwr.mm7044e3. View